Equities

Merit Medical Systems Inc

Merit Medical Systems Inc

Actions
  • Price (USD)29.77
  • Today's Change-0.23 / -0.77%
  • Shares traded950.65k
  • 1 Year change-48.35%
  • Beta1.1006
Data delayed at least 15 minutes, as of Dec 13 2019 21:00 GMT.
More ▼

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Within its segments, the Company offers products focused in four product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, and endoscopy.

  • Revenue in USD (TTM)970.18m
  • Net income in USD22.05m
  • Incorporated1987
  • Employees5.78k
  • Location
    Merit Medical Systems Inc1600 W Merit PkwySOUTH JORDAN 84095-2416United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttp://www.merit.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
MMSI:NSQ since
announced
Transaction
value
Brightwater Medical IncDeal completed17 Jun 201917 Jun 2019Deal completed-48.47%50.00m
Vascular Insights LLCDeal completed17 Dec 201817 Dec 2018Deal completed-47.10%60.00m
Data delayed at least 15 minutes, as of Dec 13 2019 21:00 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cryolife Inc274.32m1.38m968.35m1.10k731.863.4950.693.530.03530.04187.397.400.4721.965.52249,385.500.23871.370.25471.5066.2265.250.50562.433.151.290.444130.4938.5513.30-190.11--5.93--
Natus Medical Inc504.75m-20.39m1.05bn1.73k--2.5964.832.09-0.6086-0.865415.0111.910.78672.744.39291,931.80-3.183.52-3.974.1557.7558.83-4.044.611.363.620.14850.005.979.06-7,025.12--18.21--
Varex Imaging Corp780.60m16.60m1.20bn2.00k72.792.6931.781.530.42890.428920.2811.620.76962.165.29--1.676.042.027.1932.8236.032.176.841.092.400.4622--0.9312.64-18.23-31.50----
AtriCure Inc.222.38m-23.69m1.21bn620.00--4.67--5.42-0.6353-0.60365.986.530.53412.338.88358,675.80-5.69-10.31-6.28-11.7973.8271.94-10.65-16.232.49-12.870.2177--15.4019.7513.37--16.74--
Inmode Ltd138.14m41.89m1.24bn209.0031.847.7429.408.991.221.224.105.021.072.5719.20697,686.9032.53--39.34--86.87--30.38--7.47--0.00--87.37--165.91------
Tactile Systems Technology Inc178.88m9.04m1.28bn499.00145.6712.32100.257.170.46250.46259.155.471.465.607.48358,470.907.376.708.848.2050.1949.445.064.473.56--0.000.0031.5431.06-6.1274.1092.20--
Atrion Corporation155.53m36.45m1.31bn570.0035.975.6227.898.4019.5719.5783.52125.230.6422.407.87272,852.6015.0416.4315.8117.3345.5247.9623.4320.819.35--0.0024.093.992.923.345.2012.6416.27
Shockwave Medical Inc-100.00bn-100.00bn1.38bn162.00--11.62----------3.83------------------------6.28--0.1402--613.38---34.25------
Inogen Inc369.56m32.37m1.56bn1.10k48.804.5335.084.211.451.4516.5015.600.92185.819.80336,266.608.0711.719.1713.4249.1248.898.7611.035.11--0.000.0043.5736.5581.40200.6722.30--
Avanos Medical Inc677.70m-46.40m1.56bn4.70k--1.22--2.30-0.9755-0.882914.2426.550.37112.144.38144,191.50-2.54-1.93-2.93-2.2857.9845.66-6.85-5.281.846.690.1637--6.65-17.2170.55--0.0408--
Cardiovascular Systems Inc256.24m-3.15m1.61bn731.00--11.313,835.066.27-0.0931-0.09317.554.041.232.657.89350,534.90-1.51-9.79-1.88-12.1980.5780.43-1.23-8.663.04--0.1284--14.2712.67-114.89---23.33--
Merit Medical Systems, Inc.970.18m22.05m1.64bn5.78k76.491.7314.991.690.38920.332517.2817.190.63172.747.08167,764.001.442.981.593.3243.8544.302.274.341.474.930.31670.0021.2814.4752.1322.241.65--
STAAR Surgical Company142.49m8.77m1.67bn475.00200.0711.18135.8611.720.18710.18713.043.350.80112.235.23299,974.804.93-4.995.88-6.8274.4870.306.15-4.134.96124.380.0233--36.8011.4141.1865.68-8.22--
Inspire Medical Systems Inc71.70m-28.94m1.73bn165.00--11.81--24.08-1.18-1.182.856.080.45683.258.75434,563.60-18.44---19.71--82.43---40.36--13.05--0.1435--77.10---24.65------
Patterson Companies, Inc.5.58bn53.44m1.99bn7.80k36.621.3714.800.35690.56820.596959.3315.211.655.549.68715,493.101.554.512.215.9121.5723.430.94092.870.84799.970.312760.461.999.23-34.90-13.9312.288.87
Glaukos Corp225.21m-19.38m2.09bn437.00--10.98--9.27-0.5274-0.52746.195.150.90462.2610.24515,357.00-7.78-10.84-8.81-12.8786.7784.85-8.60-10.645.94--0.267--13.8353.97-13,977.17--64.67--
Data as of Dec 13 2019. Currency figures normalised to Merit Medical Systems Inc's reporting currency: US Dollar USD

Institutional shareholders

50.33%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20197.56m13.69%
The Vanguard Group, Inc.as of 30 Sep 20195.52m9.99%
ArrowMark Colorado Holdings LLCas of 30 Sep 20194.09m7.40%
Conestoga Capital Advisors LLCas of 30 Sep 20192.05m3.71%
SSgA Funds Management, Inc.as of 30 Sep 20191.90m3.44%
Dimensional Fund Advisors LPas of 30 Sep 20191.64m2.97%
Macquarie Investment Management Business Trustas of 30 Sep 20191.57m2.85%
Aristotle Capital Boston LLCas of 30 Sep 20191.33m2.40%
Waddell & Reed Investment Management Co.as of 30 Sep 20191.11m2.00%
Jennison Associates LLCas of 30 Sep 20191.03m1.87%
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.